Stockreport

Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing

Eterna Therapeutics Inc.  (ERNA) 
PDF CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) announced today that it has regained compliance [Read more]